NJIT receives patent for new shunt to aid brain-injured patients
January 3, 2012 in OtherNJIT Professor Gordon Thomas and NJIT Research Professor Reginald Farrow, both in the department of physics, and NJIT alumnus Sheng Liu, formerly a doctoral student of both researchers and now an engineer at a biotech company, were awarded a patent today for the NJIT SmartShunt, a unique device to help patients with brain injuries.
The patent, entitled "No Clog Shunt Using a Compact Fluid Drag Path" (US Patent Number 8,088,091), discloses a device that enables the non-invasive wireless monitoring of both the extremely slow flow of cerebrospinal fluid as well as tiny changes in pressure in a shunt that drains fluid out of the brain. Ordinary shunts are commonly used by patients suffering from severe excess pressure in the brain due to hydrocephalus or brain injury.
"A serious problem with shunts is that they may malfunction or become obstructed. The symptoms include a severe headache, but can be confusing, particularly when patients are small children," said Thomas. Such uncertainty can lead to the performance of unnecessary and unpleasant surgical procedures or, alternatively, to the postponement of what could be life-saving medical interventions.
"The technology will enable patients and physicians to determine whether cerebrospinal fluid flow is in fact, impaired," added Farrow. The device will also allow those involved to determine better what medical procedures should be performed
The NJIT SmartShunt includes a set of components that are geared toward reducing the potential for shunt obstruction. It is designed to have a lifetime of more than a decade because it needs no internal power. "The SmartShunt will also be a valuable new tool for research into what extent diet, motion and medication of patients can improve the pressure and flow of the fluid in the brain," Thomas added.
The NJIT team has been working on this device since September 2004 with grants from New Jersey Commission on Science and Technology and most recently from the National Institutes of Health.
Provided by New Jersey Institute of Technology
-
Brain Fluid Sensor May Improve Hydrocephalus Treatment
Jul 16, 2010 |
not rated yet |
0
-
New invention could improve treatment for children with 'water on the brain'
Sep 24, 2010 |
not rated yet |
0
-
NJIT and UMDNJ license personal tonometer technology for innovative glaucoma testing
May 17, 2011 |
not rated yet |
0
-
Antimicrobial sutures reduce infections in brain shunt surgery, study finds
Jul 25, 2008 |
not rated yet |
0
-
Novel combined therapy extends life, diminishes pain in brain cancer patients
Jul 14, 2011 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011
- More from Physics Forums - Independent Research
More news stories
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Other
12 hours ago |
not rated yet |
0
Tongue analysis software uses ancient Chinese medicine to warn of disease
For 5,000 years, the Chinese have used a system of medicine based on the flow and balance of positive and negative energies in the body. In this system, the appearance of the tongue is one of the measures used to classify ...
Other
May 25, 2012 |
1 / 5 (1) |
0
|
Neck strength, cervical spine mobility don't predict pain
(HealthDay) -- Neither isometric neck muscle strength nor passive mobility of the cervical spine, two physical capacity parameters found to be associated with neck pain in other studies, predicts later neck ...
Other
May 25, 2012 |
not rated yet |
0
Pool access for the disabled sparks controversy
(AP) -- The Obama administration is sidestepping an election-year confrontation with the hotel industry and other pool owners to give them more time to comply with access rules for the disabled.
Other
May 25, 2012 |
not rated yet |
0
Chile to cover sex change operations
Chile will soon cover sex change surgeries under its public health plan in order to allow citizens of limited means to "recover their true sexual identity," Health Minister Jaime Manalich said.
Other
May 25, 2012 |
not rated yet |
0
Keep food safety in mind this memorial day weekend
(HealthDay) -- Picnics, parades and cookouts are as much a part of Memorial Day weekend as tributes to the United States' war veterans.
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.